Sign in

CIK 0000875320 · Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
043039129
Phone
6173416393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,307,135
in 1 filing, $6.3M under 10b5-1 plans

Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kewalramani Reshma −$6.3M CEO & President sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-04 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +2,566 10,066
2025-02-04 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +1,854 11,920
2025-02-04 ALTSHULER DAVID EVP, Chief Scientific Officer Grant or award +12,314 38,127
2025-02-04 ALTSHULER DAVID EVP, Chief Scientific Officer Grant or award +7,114 45,241

Page 18 of 18 · 344 trades